Cover Image
市場調查報告書

南美的體外診斷檢驗市場 (哥倫比亞、巴西、秘魯、阿根廷、智利、委內瑞拉、厄瓜多及其他各國)

The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)

出版商 Kalorama Information 商品編碼 325605
出版日期 內容資訊 英文 344 Pages
訂單完成後即時交付
價格
Back to Top
南美的體外診斷檢驗市場 (哥倫比亞、巴西、秘魯、阿根廷、智利、委內瑞拉、厄瓜多及其他各國) The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)
出版日期: 2015年01月31日 內容資訊: 英文 344 Pages
簡介

先進各國的IVD (體外診斷) 市場由於變得成熟,IVD企業對所得、生活水準上升,預計對品質好的醫療需求高漲的新興國家引起興趣。南美成為對IVD廠商來說的主要目標市場。

本報告提供南美的體外診斷檢驗市場相關研究、各國的醫療制度、保險制度、法規,及競爭情形相關調查分析、主要企業簡介,為您概述為以下內容。

第1章 摘要整理

第2章 哥倫比亞

  • 政治概要、人口統計
  • 經濟、醫療資金
  • 臨床實驗室、血庫
  • 哥倫比亞市場參與企業
  • 哥倫比亞的IVD市場
  • 哥倫比亞的IVD市場分析:各種類
  • 哥倫比亞的IVD預測
  • 結論、建議

第3章 秘魯

第4章 智利

第5章 阿根廷

第6章 巴西

第7章 烏拉圭、委內瑞拉、厄瓜多及其他的南美各國

第8章 企業簡介

  • Abbott Diagnostics
  • Alere Inc.
  • Beckman Coulter, Inc. / Danaher
  • Becton, Dickinson and Company (BD)
  • The BD MAX Enterprise
  • Veritor System - Immunoassays
  • bioMerieux Inc.
  • QIAGEN N.V.
  • Roche Diagnostics
  • The PCR Enterprise
  • Siemens Healthcare Diagnostics 、其他

附錄:經營者清單

圖表

目錄
Product Code: KLI5464816

The maturation of IVD markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new health consciousness population with growing demands for quality medical care. Latin America (LATAM) is a key target for IVD manufacturers. Kalorama Information, working in conjunction with Argentina-based VA Consultadora y Asociados, has developed a superior resource for business planners in the IVD industry considering emerging markets.

Detailed Country-by-Country Analysis of the In Vitro Diagnostic Markets of Latin America

Each country in Latin America has its own healthcare system, insurance system, regulations and competitive situation. To be useful, a report must provide a country-level analysis. This Kalorama Information report focuses on the market for reagents and instruments in the most important countries of the continent. Brazil, Chile, Colombia, Peru and Argentina are singled out for a deeper level of analysis. Uruguay, Venezuela, Ecuador and other nations are also considered. For the main country market analysis, the following data are presented:

Brazil: IVD Market and Forecast, Market Share, Insurance Statistics, Brazilian Labs Data, Brazilian Blood Bank Data Segment markets for: Clinical Chemistry, POC, Glucose, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Molecular Microbiology, Nucleic Acid Test, Flow Cytometry, Cardiac Markers

Colombia: IVD Market and Forecast, Market Share, Insurance Statistics, Colombian Labs Data and Blood Bank Statistics Segment Markets for Clinical Chemistry, Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, Flow Cytometry, Cardiac Markers.

Chile: IVD Market and Forecast, Market Share, Insurance Statistics, Chilean Labs Data and Blood Bank Statistics. Segment Markets for Clinical Chemistry, Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, Flow Cytometry, Cardiac Markers

Argentina: IVD Market and Forecast, Market Share, Insurance Statistics, Argentinean Labs Data and Blood Bank Statistics. Segment Markets for Clinical Chemistry, Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, Flow Cytometry, Cardiac Markers.

Peru: IVD Market and Forecast, Market Share, Insurance Statistics, Peruvian Labs Data and Blood Bank Statistics. Segment Markets for Clinical Chemistry, Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, Flow Cytometry, Cardiac Markers)

Top level IVD markets and forecasts are provided for Ecuador, Venezuela, Uruguay and Other LATAM. The report also contains competitor profiles, population and economic statistics, country market comparisons and analyst conclusions.

Superior Market Share Analysis: Significant Country and Segment Shares

While Latin America is a recognized opportunity for major IVD competitors, it is a familiar region for many as well. Major firms have been in Brazil for decades. Competition in these countries. But each country has its own competitive dynamics. Different companies lead in different segments of testing in this countries. A leader in Argentina may not be in Colombia and so on and so forth. Kalorama illuminates these differences with market share for each major nation in the region. In many cases, where it can be reliably determined, Kalorama provides segment level market share by-country.

Segment-level Market Sizing

Know the market opportunity for the area of IVD that you compete in or invest in. Kalorama Information's proprietary market sizing provides knowledge of the total manufacturer earnings in a given market within each major country. The segments under analysis include reagents, consumables, calibrators and controls of the following sub-segments: Clinical Chemistry, Hematology, Immunology, Microbiology Immunoassays, Coagulation, Blood Banking, Urinalysis, Microbiology, Molecular Microbiology, Nucleic Acid Testing, Flow Cytometry, Primary Staining Histology, Advanced Staining Histology, Cardiac Markers.

Kalorama Information only publishes reports in healthcare and specializes in IVD with subspecialties in biotechnology and devices. Kalorama is the publisher of the Worldwide Market for In Vitro Diagnostics. In nine editions, it is used by major IVD companies for their business development and planning efforts. Kalorama now applies its method to the Latin American market - secondary research into company financial statements, medical and government literature, combined with primary research (interviews) with distributors, manufacturers and end users. This research is then considered by an experienced analyst. In this effort, Kalorama has partnered with VA Consultora, a recognized market research and laboratory survey company in Buenos Aires, Argentina with networks of IVD market watchers in every major Latin American capital.

Detailed Competitive Analysis

There is robust competition in the Latin American IVD market. Knowing who is in the market will enable business executives to understand and benchmark their efforts and also provide models for success in the market. This report cites the key competitors in each country and their main strengths. Companies Analyzed in the report include.

  • Abbott
  • Albis
  • Andina Medica
  • Becton Dickinson
  • Belomed SRL
  • Biomed
  • Bio-Rad
  • BioTechnica
  • Biomedical Systems
  • Biomerieux
  • Diagnostica Peruana
  • Diamed Argentina
  • DiaSorin
  • Farmalatina Ltda
  • Felsan SA
  • Galenica
  • Gematec
  • Grifols Chile S.A
  • Horiba ABX
  • Ortho-Clinical Diagnostics .
  • Qiagen
  • Wama
  • Wiener Lab/Labinbraz
  • Jampar Multiplest Internacional
  • Johnson & Johnson
  • Labin Peru
  • Labin Wiener
  • Medicatec SRL
  • Tecnigen S.A.
  • Química Suiza S.A.
  • Representaciones Médicas del Peru S.R. Ltda.
  • Roche Diagnostics
  • Siemens Healthcare
  • WM Argentina

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Overview
  • Size of the Market and Growth
    • Latin American IVD Market by Country
    • Growth of IVD Market in Latin America by Country, 2014 to 2019
    • IVD Company Market Share in Latin America
  • Segments Definition
  • Market Leadership in IVD Segments
  • IVD Market Opportunity by Country
  • Research Methodology

TWO: COLOMBIA

  • Political Overview and Demographics
  • Economy and Health Funding
    • History
    • Health Overview by Sector
    • Health Insurance Providers (EPS)
    • Health Expenditure as Percentage of GDP
    • Health Expenditure by Sector
    • Health Service Providers (IPS)
  • Clinical Laboratories and Blood Banks
    • Blood Banks
  • Companies Present in the Colombian Market
    • Abbott Laboratorios de Colombia SA
    • Annar Diagnóstica
    • Becton Dickinson de Colombia Ltda
    • Biocientífica Ltda
    • Biomerieux Colombia Ltda
    • Biolore Ltda
    • Biosystems SA
    • Johnson & Johnson de Colombia SA
    • Labcare de Colombia Ltda
    • Laboratorio DAI de Colombia
    • Merck SA
    • Nipro Medical Corporation
    • Quik Ltda
    • Representaciones Labin Venezuela
    • Roche Diagnostics
    • Rochem Biocare
    • Siemens SA
  • Colombia IVD Market
    • Market Share
  • Colombian IVD Market Analysis by Segment
    • Clinical Chemistry Market in Colombia
    • Hematology Market in Colombia
    • Immunoassays Market in Colombia
    • Microbiology ImmunoassaysMarket in Colombia
    • Coagulation Market in Colombia
    • Blood Banking Market in Colombia
    • Urinalysis Market in Colombia
    • Microbiology Market in Colombia
    • Molecular Microbiology and Nucleic Acid Tests Market in Colombia
    • Emergency Tests and POC Market in Colombia
    • Histology Market in Colombia
    • Flow Cytometry Market in Colombia
  • Colombian IVD Forecast 2014-2017
  • Conclusions and Recommendations

THREE: PERU

  • Political Overview and Demographics
    • Political Overview
    • Demographics
  • Economy and Health Funding
    • History of the Healthcare System of Peru
  • Health Overview by Sector
    • Public Sector
    • Private Sector
  • Uninsured Population
    • Population Insured by the Integral Health Insurance (SIS)
    • Health Facilities in Peru
  • Health Expenditure as Percentage of GDP
    • Increased Healthcare Demand
  • Clinical Laboratories and Blood Banks
    • Clinical Laboratories
    • Blood Banks in Peru
  • Companies Present in the Market
    • Albis
    • Andina Medica
    • Becton Dickinson del Uruguay SA Peru Branch
    • Belomed SRL
    • Biomed
    • Biomedical Systems
    • Diagnostica Peruana
    • Jampar Multiplest Internacional
    • Johnson & Johnson del Peru
    • Labin Peru
    • Química Suiza S.A.
    • Representaciones Médicas del Peru S.R. Ltda
    • Roche Diagnostics
    • Rochem Biocare
  • Peru IVD Market Size
  • Peruvian IVD Market Share by Company
  • Peru IVD Market 2013 by IVD Segment
    • Clinical Chemistry Market in Peru
    • Hematology Market in Peru
    • Immunoassays Market in Peru
    • Microbiology ImmunoassaysMarket in Peru
    • Coagulation Market in Peru
    • Blood Banking Market in Peru
    • Urinalysis Market in Peru
    • Microbiology Market in Peru
    • Molecular Microbiology and Nucleic Acid Tests Market in Peru
    • Emergency Tests and POC Market in Peru
    • Histology Market in Peru
    • Flow Cytometry Market in Peru
  • IVD Market in Tests, by Sector
  • Peru IVD Forecast, 2014-2017
  • Conclusions and Recommendations

FOUR: CHILE

  • Overview and Demographics
  • Demographics
  • Economy and Health Funding
    • History
  • Health Insurance System Overview
    • FONASA
    • ISAPRES
    • General Physicians
    • Hospitals and Clinics
    • Lab Tests Prescription
  • Expenditure in Health
    • Clinical Diagnostics Expenditure
  • Diagnostic Laboratories and Blood Banks in Chile
    • Clinical Labs
    • Blood Banking Market in Chile
  • Chilean IVD Market by Company
    • Abbott Diagnostics
    • Alatheia Medical
    • Becton Dickinson
    • Biomerieux
    • Farmalatina Ltda
    • Galenica
    • Grifols Chile S.A.
    • GrupoBios Chile
    • Johnson & Johnson
    • Labin Wiener
    • Merck S.A.
    • Roche
    • Siemens Healthcare
    • Tecnigen S.A.
    • Valtek Diagnostics
  • Chilean IVD Market and Forecast
  • Chilean IVD Market Share by Company
  • IVD Market Size in US$: Distribution by Segment
    • Clinical Chemistry Market in Chile
    • Hematology Market in Chile
    • Immunoassays in Chile
    • Microbiology Immunoassaysin Chile
    • Coagulation in Chile
    • Blood Banking in Chile
    • Urinalysis in Chile
    • Microbiology in Chile
    • Molecular Microbiology in Chile
    • Flow Cytometry in Chile
    • Cardiac Markers (non POC) in Chile
    • Histology in Chile
    • Point of Care and Emergency Tests in Chile
    • Chilean Diabetes Market
  • Market Size in Tests and by Health Sector (Excluding Diabetes)
    • Growth of Anatomy Pathology
    • Average Reimbursement per Test
  • IVD Market Growth
    • Expected Evolution 2014-2017
  • Conclusions and Recommendations

FIVE: ARGENTINA

  • Overview and Demographics
    • Overview
    • Demographics
  • Economy and Health Funding
    • History of the Healthcare System of Argentina
    • Health Overview by Sector
    • Health Expenditure as Percentage of GDP
    • Health Expenditure by Sector
    • Clinical Laboratories and Blood Banks
    • Clinical Laboratories
    • Rate of Use
  • Clinical Laboratories Segmentation
    • Differential Growth by Test Group
    • Blood Banks
  • Companies Present in the Argentinian Market
    • Abbott Diagnostics
    • Becton Dickinson Argentina
    • Bioars SA
    • Biodiagnostico SA
    • Biomerieux
    • Cromoion SRL
    • Diamed Argentina SA
    • Felsan SA
    • Gematec SRL
    • Grifols Argentina SA
    • Johnson & Johnson Argentina
    • Medicatec SRL
    • Rochem Biocare
    • Productos Roche SA
    • Siemens Healthcare Argentina
    • Tecnolab SA
    • Wiener Lab
    • WM Argentina
  • IVD Market in Argentina
    • Market Size
    • Market Share
  • IVD Market in Argentina by Segment
    • Clinical Chemistry Market in Argentina
    • Hematology Market in Argentina
    • Immunoassays Market in Argentina
    • Microbiology ImmunoassaysMarket in Argentina
    • Coagulation Market in Argentina
    • Coagulation Market in Argentina, Estimate and Forecast, 2014-2019
    • Blood Banking Market in Argentina
    • Urinalysis Market in Argentina
    • Microbiology Market in Argentina
    • Molecular Microbiology and Nucleic Acid Tests Market in Argentina
    • Cardiac Markers (non POC) Market in Argentina
    • Emergency Tests and POC Market in Argentina
    • Histology Market in Argentina
    • Flow Cytometry Market in Argentina
    • Diabetes Market in Argentina
  • Distribution of Tests
  • Argentina Market Forecast, 2014-2017
  • Conclusions and Recommendations

SIX: BRAZIL

  • Introduction
  • Current Economic Considerations
  • Healthcare in Brazil
    • Brazil's Status in Key Healthcare Areas
  • How Healthcare Functions In Brazil
  • Regulation
  • Market Analysis
    • IVD Sector
  • Brazilian IVD Market by Segment
    • Clinical Chemistry Market in Brazil
    • Point Of Care Testing Market in Brazil
    • Diabetes Testing in Brazil
    • Immunoassays Market in Brazil
    • Microbiology Market in Brazil
    • Cardiac Markers Market in Brazil
    • Urinalysis Market in Brazil
    • Molecular Testing Market in Brazil
    • Coagulation Market in Brazil
    • Histology Market in Brazil
    • Hematology Market in Brazil
    • Blood Testing and Typing Market in Brazil
    • Flow Cytometry Market in Brazil
  • Competitive Analysis
    • Abbott
    • bioMerieux
    • Beckman Coulter
    • DiaSorin
    • Bio-Rad
    • BioTechnica
    • BD (Becton-Dickinson)
    • Hemogram Indústria e Comercio de Produtos Hospitalares
    • Horiba ABX
    • Labtest
    • Ortho-Clinical Diagnostics
    • Qiagen
    • Roche
    • Siemens Medical Solutions Diagnostics
    • Wama
    • Wiener Lab/Labinbraz

SEVEN: URUGUAY, VENEZUELA, ECUADOR AND THE REST OF LATIN AMERICA

  • Brief Economic Overview
  • GDP in the Latin American Region
  • Health Expenditure in Latin America
    • Health Systems in Latin America
    • Health Expenditure and Financing
  • Latin America In Vitro Diagnostics Market Overview
    • IVD Spending per Capita
  • Clinical Labs in LATAM, Overview
  • Conclusions and Recommendations

EIGHT: COMPANY PROFILES

  • Abbott Diagnostics
    • Core Lab
    • Immunoassays
    • Hematology
    • Histology
    • Blood Bank
    • Point of Care
  • Alere Inc.
    • HIV
    • Lab-based
    • Microbiology
  • Beckman Coulter, Inc. / Danaher
    • Core Lab
    • Hematology
    • Immunoassays
    • Flow Cytometry
  • Becton, Dickinson and Company (BD)
    • Initiatives
    • Traditional Microbiology
    • Blood Culture
  • The BD MAX Enterprise
    • HPV
  • Veritor System - Immunoassays
    • Continuous Blood Glucose
    • Flow Cytometry
    • Histology
    • Mass Spectrometry
  • bioMérieux Inc.
    • Expansion
  • I mmunoassays
    • Blood Culture
  • QIAGEN N.V.
    • TB Testing
    • HPV
  • Roche Diagnostics
  • Reorganization
  • The PCR Enterprise
    • Core Lab
    • Immunoassays
    • Diabetes
    • Point of Care
    • Coagulation
    • Blood Bank
  • Siemens Healthcare Diagnostics
    • Core Lab
    • Immunoassays
    • Coagulation
    • Urinalysis
    • Critical Care
    • Molecular
  • About VA Consultora y Asociados

LIST OF EXHIBITS

  • ONE: EXECUTIVE SUMMARY
  • Table 1-1: GDP in Select Latin American Countries (Brazil, Argentina, Colombia,Venezuela, Peru, Chile, Ecuador, Uruguay)
  • Figure 1-1: IVD Market in Latin America, 2014-2019
  • Figure 1-2: Latin American IVD Market by Country (Argentina, Brazil, Colombia, Chile,
  • Ecuador, Peru, Venezuela, Uruguay, Other LATAM)
  • Figure 1-3: Average Growth of IVD Market in Latin America by Country, 2014 to 2019(Argentina, Brazil, Chile, Colombia, Peru, Others)
  • Figure 1-4: IVD Market Growth, 2014 - 2019, by Country, in Both Dollar Volume andGrowth (Argentina, Brazil, Chile, Colombia, Ecuador, Peru, Uruguay, Venezuela, Other)
  • Figure 1-5: IVD Market Share in Latin America, by Company
  • Table 1-2: Latin American Market Leaders in Selected Segments (Clinical Chemistry,Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation,Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, FlowCytometry, Cardiac Markers)
  • Table 1-3: Nations' IVD Markets Compared: Advantages, Challenges
  • TWO: COLOMBIA
  • Table 2-1: Population of Colombia in Major Urban Centers
  • Table 2-2: Colombian Insurance Perspective (% of Enrollment Contributory Regime,
  • Enrollment Subsidiary, % of Population Not Enrolled)
  • Table 2-3: Top Ten Health Insurance Providers According to the Number of Enrolled Individuals
  • Figure 2-1: Colombian GDP Evolution
  • Table 2-4: Payors of Healthcare in Colombia
  • Table 2-5: Colombian Clinical Labs by Department
  • Table 2-6: Bogotá and Cundinamarca Lab Classification (High, Medium, Low)
  • Figure 2-2: Distribution of Blood Banks in Colombia
  • Table 2-7: Colombia IVD Estimated Market Share
  • Figure 2-3: Colombian IVD Estimated Market Share by Company
  • Figure 2-4: Clinical Chemistry Market in Colombia, Estimate and Forecast, 2014-2019
  • Figure 2-5: Clinical Chemistry Market in Colombia, Market Share
  • Figure 2-6: Hematology Market in Colombia Market, Estimate and Forecast, 2014-2019
  • Fiigure 2-7: Hematology Market in Colombia, Market Share
  • Fiigure 2-8: Immunoassay Market in Colombia, Market Estimate and Forecast, 2014-2019
  • Fiigure 2-9: Immunoassay Market in Colombia, Market Share
  • Figure 2-10: Immunoassay Microbiology Market in Colombia, Estimate and Forecast,2014-2019
  • Figure 2-11: Immunoassay Microbiology Market in Colombia, Market Share
  • Figure 2-12: Coagulation Market in Colombia, Estimate and Forecast, 2014-2019
  • Figure 2-13: Coagulation Market in Colombia, Market Share
  • Figure 2-14: Blood Banking Market in Colombia, Estimate and Forecast, 2014-2019
  • Figure 2-15: Blood Banking Market in Colombia, Market Share
  • Figure 2-16: Urinalysis Market in Colombia, Estimate and Forecast, 2014-2019
  • Figure 2-17: Urinalysis Market in Colombia, Market Share
  • Figure 2-18: Microbiology Market in Colombia, Estimate and Forecast, 2014-2019
  • Figure 2-19: Microbiology Market in Colombia, Market Share
  • Figure 2-20: Molecular Microbiology in Colombia, Estimate and Forecast, 2014-2019
  • Figure 2-21: Molecular Microbiology Market in Colombia, Market Share
  • Figure 2-22: Emergency Tests and POC Market in Colombia, Estimate and Forecast, 2014-2019
  • Figure 2-23: Histology Market in Colombia, Estimate and Forecast, 2014-2019 (Primary,
  • Advanced)
  • Figure 2-24: Flow Cytometry Market in Colombia, Estimate and Forecast, 2014-2019
  • Figure 2-25: Flow Cytometry Market in Colombia, Market Share
  • Table 2-8: Colombian IVD Market (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine Tests, Microbiology,Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, CardiacMarkers, Glucose Testing, POC/Emergency Tests)
  • Figure 2-26: Colombian IVD Market, Percentage (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine
  • Tests, Microbiology, Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry,Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • THREE: PERU
  • Table 3-1: Peru Population Demographics (Urban/Rural, Poverty, Extreme Poverty,Economically Active, Unemployment, GDP, GDP/Capita, Exchange Rate)
  • Figure 3-1: Population Density by Departments (Provinces) of Peru
  • Figure 3-2: Peru, Percentage of Population by Health Administrator, 2013
  • Table 3-2: Peru, Population Insured by Integral Health Insurance (SIS)
  • Table 3-3: Expenditure in Health in Millions of New Peruvian Soles
  • Table 3-4: Out of Pocket IVD Healthcare Expense in Local Currency (Nuevos Soles), Peru,2011
  • Table 3-5: Clinical Laboratories in Peru, By Department
  • Table 3-6: Peru IVD Sales by Segment (Clinical Chemistry, Hematology ImmunoassaysNon-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine Tests, Microbiology,Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • Figure 3-3: Peruvian IVD Market, Market Share by Company
  • Figure 3-4: Peru IVD Market by Segment (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine Tests, Microbiology, Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • Figure 3-5: Clinical Chemistry Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-6: Clinical Chemistry Market in Peru, Market Share
  • Figure 3-7: Hematology Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-8: Hematology Market in Peru, Market Share
  • Figure 3-9: Immunoassays Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-10: Immunoassays Market in Peru, Market Share
  • Figure 3-11: Microbiology ImmunoassaysMarket in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-12: Microbiology Immunoassays Market in Peru, Market Share
  • Figure 3-13: Coagulation Market in Peru, Estimate and Forecast, 2014 to 2019
  • Figure 3-14: Coagulation Market in Peru, Market Share
  • Figure 3-15: Blood Banking Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-16: Blood Banking Market in Peru, Market Share
  • Figure 3-17: Urinalysis Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-18: Urinalysis Market in Peru, Market Share
  • Figure 3-19: Microbiology Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-20: Microbiology Market in Peru, Market Share
  • Figure 3-21: Molecular Microbiology and Nucleic Acid Tests Markets in Peru, Estimates and Forecasts, 2014-2019
  • Figure 3-22: Molecular Microbiology and Nucleic Acid Tests Markets in Peru, Market Share
  • Figure 3-23: Emergency Tests and POC Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-24: Histology Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-25: Histology Market in Peru, Market Share
  • Figure 3-26: Flow Cytometry Market in Peru, Estimate and Forecast, 2014-2019
  • Figure 3-27: Flow Cytometry Market in Peru, Market Share
  • Table 3-7: Peruvian Health Coverage (Coverage Agency, Members, Tests, Rate of Use)
  • Figure 3-28: Peru IVD Market Growth to 2019
  • FOUR: CHILE
  • Figure 4-1: Chile, Outline of Universal Access with Explicit Guarantees (Acceso Universal con Garantias Explícitas - AUGE or GES)
  • Figure 4-2: Coverage in Chile's SHI System, 2011
  • Table 4-1: List of ISAPRES (Total 13)
  • Figure 4-3: Laboratories in Chile
  • Figure 4-4: Labs in Chile, PEEC-Subscribed and Others, by Geographic Area
  • Table 4-2: Clinical Labs in Chile (Average Tests/Year, Number of Labs, Private Sector, Public Sector)
  • Table 4-3: Market Share by Type of Infectious Disease Test, Chile
  • Table 4-4: Chilean IVD Market 2014-2019 (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine Tests, Microbiology, Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • Table 4-5: Chilean IVD Market Share by Company
  • Figure 4-5: Chilean IVD Market Share by Company
  • Figure 4-6: Chilean IVD Market, Distribution by Segment (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine Tests, Microbiology, Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • Figure 4-7: Clinical Chemistry Market in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-9: Hematology Market in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-10: Hematology in Chile Market Share
  • Figure 4-11: Immunoassays in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-12: Immunoassays in Chile, Market Share
  • Figure 4-13: Microbiology Immunoassays in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-14: Microbiology Immunoassays in Chile, Market Share
  • Figure 4:15: Coagulation in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-16: Coagulation in Chile, Market Share
  • Figure 4-17: Blood Banking in Chile Estimate and Forecast, 2014-2019
  • Figure 4-18: Blood Banking in Chile, Market Share
  • Figure 4-19: Urinalysis in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-20: Urinalysis in Chile Market Share
  • Table 4-6: Focus on Chilean Microbiology Segment Tests Per Year (Total, Bacteria and Fungi, Parasite, Virus)
  • Figure 4-21: Microbiology in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-22: Microbiology in Chile, Market Share
  • Figure 4-23: Molecular Microbiology in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-24: Molecular Microbiology in Chile, Market Share
  • Figure 4-25: Flow Cytometry Market in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-26: Flow Cytometry in Chile, Market Share
  • Figure 4-27: Cardiac Markers (non POC) in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-28: Cardiac Markers (non POC) in Chile, Market Share
  • Figure 4-29: Histology Market in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-30: Histology Market in Chile, Market Share
  • Figure 4-31: Point of Care and Emergency Tests in Chile, Estimate and Forecast, 2014- 2019
  • Figure 4-32: Prevalence of Diabetes in Chile, 2012
  • Figure 4-33: Diabetes Market in Chile, Estimate and Forecast, 2014-2019
  • Figure 4-34: Diabetes in Chile, Market Share
  • Table 4-7: Number of Tests (2011-2013) by Health Sector and the Average Number of
  • Tests by Physician Order (Prescription), Chile
  • Table 4-8: Annual Clinical Diagnostic Labs Income, Chile (2011-2013)
  • Table 4-9: Anatomy Pathology, Chile (2011-2013)
  • Table 4-10: Average Reimbursement Price per Test, Chile (2011-2013)
  • Figure 4-35: IVD Market in Chile, Estimate and Forecast, 2014-2019
  • FIVE: ARGENTINA
  • Table 5-1: Key Facts, Argentina (GDP, Population, GDP Per Capita, GDP Growth, Industrial Production, Unemployment, Inflation, Interest Rate, Exports, Debt)
  • Figure 5-1: Healthcare Expenditure in Argentina (Public Sector, Health Security System, PAMI, Private Health Companies, Out of Pocket)
  • Figure 5-2: % of Beneficiaries by System (PAMI, OSECAC, UATRE, OS Construccion, UPCN, OS Gastronomics, Comisarios Navales, UOM, Rest)
  • Figure 5-3: Argentina Healthcare Insurance Companies by No. of Beneficiaries (OSDE, SMG, Galeno, Medicus, Omint, ASE-Medlife, H. de Comunidad, Rest)
  • Figure 5-4: Clinical Lab Tests in Argentina, 2010-2013
  • Table 5-2: Argentinian Test Volume, per VA Consultora y Asociados Survey
  • Table 5-3: Argentinian IVD Market by Sector, 2014-2019 (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine Tests, Microbiology, Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • Table 5-4: IVD Market Share by Company, Argentina
  • Figure 5-5: Argentinian IVD Market, Company Market Share
  • Figure 5-6: Argentinian IVD Market by Sector (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine
  • Tests, Microbiology, Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • Figure 5-7: Clinical Chemistry Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-8: Clinical Chemistry Market in Argentina, Market Share
  • Figure 5-9: Hematology Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-10: Hematology Market in Argentina, Market Share
  • Figure 5-11: Immunoassays Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-12: Immunoassays in Argentina, Market Share
  • Figure 5-13: Microbiology ImmunoassaysMarket in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-14: Microbiology Immunoassays Market, Market Share
  • Figure 5-15: Coagulation Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-16: Coagulation Market in Argentina, Market Share
  • Figure 5-17: Blood Banking Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-18: Blood Banking Market Share, Infectious Disease Screening
  • Figure 5-19: Urinalysis Market in Argentina, Estimate and Forecast, 2014 to 2019
  • Figure 5-20: Urinalysis Market in Argentina, Market Share
  • Figure 5-21: Microbiology Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-22: Microbiology Market in Argentina, Market Share
  • Figure 5-23: Microbiology Molecular Nucleic Acid Tests Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-24: Molecular Microbiology and Nucleic Acid Tests in Argentina, Market Share
  • Figure 5-25: Cardiac Markers (non POC) Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-26: Emergency Tests and POC Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-27: Histology Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-28: Histology Market in Argentina, Market Share
  • Figure 5-29: Flow Cytometry Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-30: Flow Cytometry Market in Argentina, Market Share
  • Figure 5-31: Diabetes Market in Argentina, Estimate and Forecast, 2014-2019
  • Figure 5-32: Diabetes Market in Argentina, Market Share
  • Table 5-5: Distribution of Tests in Buenos Aires and Buenos Aires Province
  • Figure 5-33: Argentinian IVD Market Growth, 2014-2019
  • SIX: BRAZIL
  • Figure 6-1: Population of Brazil, 2004-2012
  • Figure 6-2: GDP Growth in Brazil, 2006-2014
  • Figure 6-3: Inflation in Brazil, 2009-2014
  • Table 6-1: Labs in Brazil (Commercial Labs, Hospital Labs, Total)
  • Figure 6-4: Brazilian IVD Market by Sector (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine Tests, Microbiology, Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • Figure 6-5: Brazilian IVD Market, 2014-2019 (Clinical Chemistry, Hematology Immunoassays Non-Micro, Immunoassays Micro, Coagulation, Blood Banking, Urine Tests, Microbiology, Molecular Microbiology, Nucleic Acid Tests, Flow Cytometry, Primary Histology, Cardiac Markers, Glucose Testing, POC/Emergency Tests)
  • Figure 6-6: Clincal Chemistry Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-7: Clincal ChemistryMarket in Brazil, Market Share
  • Figure 6-8: Point of Care Testing Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-9: Diabetes Market in Brazil, Market Share
  • Figure 6-10: Immunoassays Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-11: Immunoassays Market in Brazil, Market Share
  • Figure 6-12: Microbiology Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-13: Microbiology Market in Brazil, Market Share
  • Figure 6-14: Cardiac Markers Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-15: Urinalysis Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-16: Molecular Microbiology and Nucleic Acid Tests Markets in Brazil, Estimates and Forecasts, 2014-2019
  • Figure 6-17: Coagulation Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-18: Primary Histology and Advanced Histology (IHC, ISH, FISH) Markets in
  • Brazil, Estimates and Forecasts, 2014-2019
  • Figure 6-19: Hematology Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-20: Blood Testing and Typing Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-21: Flow Cytometry Market in Brazil, Estimate and Forecast, 2014-2019
  • Figure 6-22: Flow Cytometry Market in Brazil, Market Share
  • Table 6-2: Company Market Share, Brazil
  • Figure 6-23: Brazilian IVD Market, Company Market Share
  • SEVEN: URUGUAY, VENEZUELA, ECUADOR AND THE REST OF LATIN AMERICA
  • Table 7-1: GDP in Select Latin American Countries (Brazil, Argentina, Colombia, Venezuela, Peru, Chile, Ecuador, Uruguay)
  • Table 7-2: "Reporte de las Américas" PAHO 2012: Health Overview by Sector
  • Table 7-3: IVD in Latin America (Argentina, Brazil, Chile, Colombia, Ecuador, Peru, Uruguay, Venezuela, Other LATAM), 2014-2019
Back to Top